Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies
This medicine is also used to lower the risk of heart attack, stroke, or death in patients with type 2 diabetes, obesity, and heart or blood vessel disease
[13] Neither the participant nor the health care provider knew which treatment was being given until after the trials were completed
For endurance athletes, it might mean better performance during critical surges or repeated high-intensity efforts
(2012) in Journal of Aging Research confirmed that GHK-Cu increased skin density and thickness, counteracting the natural decline in GHK-Cu levels (from 200 ng/ml at age 20 to 80 ng/ml at age 60) that exacerbates wrinkles (Pickart et al., 2012)
The results from a 48-week phase 2 trial in patients with obesity who are at risk of developing cardiovascular diseases, showed that patients had achieved a mean weight loss of 15.6% on a 2.4 mg dose of the drug, and notably, improvements in blood pressure as well as no cardiac event imbalances took place